Immunobiology
Featured Research
Targeting MicroRNA Emerges As Potential Weapon Against Acute Myelogenous Leukemia
When acute myelogenous leukemia (AML) strikes, five-year survival rates vary dramatically (15 percent–70 percent) depending upon the AML subtype. Children diagnosed with AMLs with 11q23 translocations have experienced especially poor outcomes.
Read More
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
